TotalSeq™-B0028 anti-human CD30 Antibody, CD30, BY88,BioLegend,333921

Additional reported application: in combination with IL-2 and PMA to induce T cell clone proliferation.

Host

Mouse

Reactivity

Human

Application

PG -Quality tested

Platform ID

BAB150228529

BioLegend

Headquarters

8999 BioLegend Way San Diego, CA 92121 United States

Contact

Tel: 1-858-455-9588
Fax: +49 (4131) 7023913

Email:

Product Specifications
Scientific Background

Specifications

NameTotalSeq™-B0028 anti-human CD30 Antibody, CD30, BY88
Cat. No.333921
HostMouse
RRIDAB_2832656 (BioLegend Cat. No. 333921)
IsotypeMouse IgG1, κ
ReactivityHuman
ApplicationPG -Quality tested
ClonalityMonoclonal
Clone NumberBY88
Concentration0.5 mg/mL
TargetCD30
ImmunogenRecombinant human CD30 boosted with THP-1 cell line
PurityThe antibody was purified by chromatography and conjugated with TotalSeq™-B oligomer under optimal conditions.
FormulationPhosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and EDTA
StorageThe antibody solution should be stored undiluted between 2°C and 8°C.Do not freeze.
Regulatory StatusResearch Use Only

Scientific Background

CD30, also known as Ki-1 antigen, lymphoid activation antigen CD30, and tumor necrosis factor receptor superfamily member 8 is a type I transmembrane receptor that contains four TNF receptor domains with an approximate molecular weight of 64 kD. CD30 is highly expressed on Hodgkins and Reed-Sternberg cells as well as activated, but not resting, T and B cells. CD30 has been shown to interact with a number of proteins including TRAF1, TRAF2, TRAF3, TRAF5, NPM-ALK, TRAF-interacting protein, and CD30 ligand (CD153). Signaling through CD30 is thought to limit the proliferative potential of autoreactive CD8 effector T cells and protect against autoimmunity.

Category Paths

Request a product

Please provide the required information below so that we can quickly source your products.